<?xml version="1.0" encoding="UTF-8"?>
<p>During a pandemic, cancer patients will be classified as either confirmed infection or at high risk for COVID‐19. Patients who have confirmed COVID‐19 infection should be assessed for holding anticancer therapy until they are deemed medically clear as per the clinical guidance found on the WHO and CDC websites 
 <xref rid="onco13306-bib-0035" ref-type="ref">35</xref>, 
 <xref rid="onco13306-bib-0052" ref-type="ref">52</xref>. Cancer patients who are on active anticancer therapy continue to be high risk and should remain vigilant for COVID‐19 symptoms. (Fig. 
 <xref rid="onco13306-fig-0001" ref-type="fig">1</xref>).
</p>
